{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:04:26Z","timestamp":1775293466324,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH R01"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijpharm.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T19:00:10Z","timestamp":1483642810000},"page":"307-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy"],"prefix":"10.1016","volume":"518","author":[{"given":"Dae Hwan","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.01.006_bib0005","first-page":"M79","article-title":"Epothilones and related structures\u2013a new class of microtubule inhibitors with potent in vivo antitumor activity","volume":"1470","author":"Altmann","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4161\/cbt.10.9.13738","article-title":"Chemotherapy and signaling: how can targeted therapies supercharge cytotoxic agents?","volume":"10","author":"Bagnyukova","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.onc.1205184","article-title":"Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2","volume":"21","author":"Basso","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0020","first-page":"6938","article-title":"Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs","volume":"62","author":"Bocci","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0025","first-page":"2325","article-title":"Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action","volume":"55","author":"Bollag","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/13543784.2011.542148","article-title":"Patupilone in cancer treatment","volume":"20","author":"Bystricky","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0035","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/macp.201400342","article-title":"In-solution structural considerations by 1H NMR and solid-state thermal properties of inulin-d-\u03b1-tocopherol succinate (INVITE) micelles as drug delivery systems for hydrophobic drugs","volume":"215","author":"Catenacci","year":"2014","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0040","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1200\/JCO.2004.12.001","article-title":"Epothilones: mechanism of action and biologic activity","volume":"22","author":"Goodin","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0050","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1158\/1535-7163.MCT-11-0987","article-title":"Antitumor activity of triolimus: a novel multidrug-loaded micelle containing paclitaxel, rapamycin, and 17-AAG","volume":"11","author":"Hasenstein","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0055","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1158\/1078-0432.CCR-03-0795","article-title":"Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator","volume":"10","author":"Kaur","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0060","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","article-title":"Multicenter phase II trial of genexol-PM, a novel cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer","volume":"18","author":"Kim","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood-2004-06-2499","article-title":"Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo","volume":"105","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drup.2007.11.003","article-title":"Targeting the PI3K\/Akt\/mTOR pathway: effective combinations and clinical considerations","volume":"11","author":"LoPiccolo","year":"2008","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0075","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0003-4975(01)02787-4","article-title":"Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis","volume":"72","author":"Nguyen","year":"2001","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/pros.20289","article-title":"Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo","volume":"65","author":"O\u2019Reilly","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0090","first-page":"3779","article-title":"STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake","volume":"9","author":"Pietras","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijpharm.2010.01.032","article-title":"Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery","volume":"389","author":"Richter","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/CAD.0b013e3283067681","article-title":"Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells","volume":"19","author":"Roforth","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0093-7754(03)70025-6","article-title":"EPO906 (epothilone B): a promising novel microtubule stabilizer","volume":"30","author":"Rothermel","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0110","first-page":"2155","volume":"7","author":"Sausville","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050817","article-title":"The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin","volume":"42","author":"Schulte","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jconrel.2009.04.024","article-title":"Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs","volume":"140","author":"Shin","year":"2009","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1021\/mp2000549","article-title":"A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs","volume":"8","author":"Shin","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0135","first-page":"2139","article-title":"Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol","volume":"63","author":"Solit","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.01.006_bib0140","article-title":"Triolimus: a multi-drug loaded polymeric micelle containing paclitaxel, 17-AAG, and rapamycin as a novel radiosensitizer","author":"Tomoda","year":"2016","journal-title":"Macromol. Biosci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T09:22:30Z","timestamp":1536139350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0378517317300066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.01.006","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}